About QYNWO
About QYNWO
Advancing Pharmaceutical Innovation Toward a Healthier Future
Company InformationCorporate CultureCorporate StrengthsTechnical Capabilities
Company InformationCorporate CultureCorporate StrengthsTechnical Capabilities
Home·About QYNWO
About QYNWO

As a chemical innovation partner serving the life sciences and electronic information industries, Qynwo Science & Technology is guided by its core mission: “Bridging Molecular Innovation and Commercial Scale to Enable the Commercialization of High-Value Chemicals.”

Location and Strategic Positioning

Headquartered in the core zone of the Biopharmaceutical Valley in Nanjing Jiangbei New Area, a state-level new area, Qynwo Scienc & Technology is deeply integrated into the Yangtze River Delta’s biopharmaceutical industry cluster. The company’s core business aligns closely with the Healthy China initiative, the continued implementation of the National 14th Five-Year Plan for Bioeconomy Development, and the strategic development of emerging industries under the 15th Five-Year Plan.

Technology Platforms

Qynwo Science & Technology has established an integrated synthesis technology platform driven by two complementary pillars: chemical synthesis and synthetic biology. Its capabilities span process development and production optimization for small-molecule drugs, high-value pharmaceutical intermediates, electronic specialty materials, and advanced catalytic materials. The company supports the entire technology transfer pathway, from laboratory research and process scale-up to large-scale manufacturing, with green pharmaceutical manufacturing and bio-based chemicals as key areas of future development.

Business Structure and Service Portfolio

Through its wholly owned subsidiary, Nanjing Qynwo Science & Technology Co., Ltd., the company focuses on delivering specialized R&D and technical services to innovative biopharmaceutical companies. This creates a synergistic operating model in which the parent company provides the underlying synthesis technology platform, while the subsidiary focuses on the specific needs of innovative drug development.

Future Outllook

Qynwo Science & Technology will continue to strengthen and advance its synthesis technology platforms, with the ambition of becoming one of the world’s most trusted partners in chemical innovation.

Mission and Vision
  • Corporate Vision
    To be the most trusted chemical innovation community in the fields of life sciences and electronic information.
  • Corporate Mission
    To bridge molecular inspiration and commercial scale, enabling the commercialization of high-end chemicals.
  • Corporate Values
    Ownership, Excellence, Partnership, Execution

Enterprise Advantages

01.Chemical CDMO Excellence Across the Value Chain

As a leading chemical CDMO in China, we specialize in full-process services covering custom synthesis, process development, and commercial production. From early-stage discovery research, through kilogram-scale scale-up at the clinical stage, to ton-scale mass production at the commercial stage, we provide clients with end-to-end, one-stop chemical R&D and manufacturing support.

02.A Trusted Global Partner, Serving Customers Worldwide

As a leading chemical CDMO in China, we specialize in full-process services covering custom synthesis, process development, and commercial production. From early-stage discovery research, through kilogram-scale scale-up at the clinical stage, to ton-scale mass production at the commercial stage, we provide clients with end-to-end, one-stop chemical R&D and manufacturing support.

03.Customer-Centric Approach, Scalable Innovation Solutions

As a leading chemical CDMO in China, we specialize in full-process services covering custom synthesis, process development, and commercial production. From early-stage discovery research, through kilogram-scale scale-up at the clinical stage, to ton-scale mass production at the commercial stage, we provide clients with end-to-end, one-stop chemical R&D and manufacturing support.

Technical Capabilities

  • Process Development and Optimization for Small-Molecule Drugs and High-Value Intermediates

    Building on its advanced pharmaceutical R&D platform, the company has developed strong expertise in small-molecule pharmaceuticals. Its core capabilities cover process development from advanced intermediates and Registered Starting Materials (RSMs) to Active Pharmaceutical Ingredients (APIs). The team specializes in synthetic route design and screening to address complex molecular synthesis challenges. By continuously adopting green chemistry technologies, the company delivers customized synthesis solutions that combine high purity with cost efficiency.

  • End-to-End Process Scale-Up and Technology Transfer (CDMO Services)

    The company provides end-to-end process development and scale-up capabilities, from gram-scale laboratory research and pilot-scale production to ton-scale commercial manufacturing. Supported by a rigorous quality management system, we ensure efficient and seamless technology transfer from laboratory processes to industrial production. Our modular manufacturing services help maintain consistent product quality and regulatory compliance throughout scale-up, enabling clients to accelerate the journey from drug development to commercialization.

  • Innovative R&D in Advanced New Materials and Electronic Chemicals

    While strengthening its pharmaceutical business, the company actively expands its technological boundaries and has built a deep presence in the new materials field. Particularly in specialty electronic materials, it possesses R&D and synthesis capabilities for high-end electronic chemicals such as photoinitiators and photoacid generators for photoresists. In addition, the company holds core technologies in novel catalytic materials and additives, enabling it to provide customized solutions for key chemical materials to the electronic information industry.

  • Comprehensive Analytical Services and Regulatory Compliance Support

    The company has established a comprehensive analytical testing platform capable of precise structural confirmation, purity testing, and performance analysis for a wide range of complex chemicals, ensuring that product quality meets standards. Backed by a professional technical team, Qynwo Science & Technology provides partners with comprehensive support for international regulatory standards and one-stop technical support services, effectively helping products meet market compliance requirements.

  • Specialized Synthesis Technology Platform

    01. Enzymatic Catalysis  Process Development; 02. Fluorination Process Development; 03. Chiral Asymmetric Synthesis; 04. Scale-Up of High-Hazard Reactions Using Continuous Flow Technology

资质荣誉

Home About QYNWO Products Careers News
Jiangsu Qynwo Science & Technology Co., Ltd. | Nanjing Qynwo Pharmaceutical Technology Co., Ltd.
Address : Floors 5–7, Building 1, Phase V Accelerator, No. 125 Huakang Road, Jiangbei New Area, Nanjing, Jiangsu Province, China
Phone : 025-5879 5577   Email : bd@qynwo.com
Copyright © 2024 Jiangsu Qynwo Science & Technology Co., Ltd.   
苏ICP备2026036078号-1    网站制作：龙媒网络
Designed by Longmei

Copyright © 2023 Shanghai Chun'an Biopharmaceutical Technology Co., Ltd All Rights Reserved
沪ICP备2024097416号-1
登录